The effect of mangiferin (MF) with exercise on bood lipids was studied in K
K-AY mice, an animal model of type 2 diabetes. MF (30 mg/kg) reduced the bl
ood cholesterol (p <0.05) and triglyceride level (p <0.01) of KK-A(y) mice
with exercise 2 weeks after oral administration when compared with the cont
rol group. Diabetes also often has elevated lipid levels. Therefore, it may
be that MF has beneficial effects on hyperlipidemia in type 2 diabetes.